Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Clinical trial NCT00104403 · COMPLETED

Trial details

NCT number: NCT00104403
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced Chemotherapy-Induced Nausea and Vomiting

Start date: 2004-12-01
Primary completion: 2006-01-01
Enrollment: 722

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.